blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2763677

EP2763677 - NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.01.2021
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  24.01.2020
FormerGrant of patent is intended
Status updated on  17.01.2020
FormerExamination is in progress
Status updated on  04.12.2019
FormerGrant of patent is intended
Status updated on  22.07.2019
FormerExamination is in progress
Status updated on  27.05.2019
FormerGrant of patent is intended
Status updated on  22.01.2019
FormerExamination is in progress
Status updated on  07.04.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Janus Biotherapeutics, Inc.
222 Third Street
Suite 2240
Cambridge, MA 02142 / US
For all designated states
Lipford, Grayson, B.
45 Grenville Road
Watertown, MA 02472 / US
For all designated states
Zepp, Charles, M.
940 North Road
Hardwick, MA 01037 / US
[2020/09]
Former [2014/33]For all designated states
Janus Biotherapeutics, Inc.
222 Third Street
Suite 2240
Cambridge, MA 02142 / US
For all designated states
Lipford, Grayson, B.
45 Grenville Road
Watertown, MA 02472 / US
For all designated states
Zepp, Charles, M.
940 North Road
Hardwick, MA 01037 / US
Inventor(s)01 / LIPFORD, Grayson, B.
45 Grenville Road
Watertown, MA 02472 / US
02 / ZEPP, Charles, M.
940 North Road
Hardwick, MA 01037 / US
 [2014/33]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2020/09]HGF Limited
Saviour House
9 St. Saviourgate
York YO1 8NQ / GB
Former [2014/42]Taylor, Kate Laura
HGF Limited
Saviour House
9 St Saviourgate
York YO1 8NQ / GB
Former [2014/33]Lunt, Mark George Francis
HGF Limited
Fountain Precinct
Balm Green
Sheffield S1 2JA / GB
Application number, filing date12837804.903.10.2012
[2020/09]
WO2012US58566
Priority number, dateUS201161543082P04.10.2011         Original published format: US 201161543082 P
[2014/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013052550
Date:11.04.2013
Language:EN
[2013/15]
Type: A2 Application without search report 
No.:EP2763677
Date:13.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 11.04.2013 takes the place of the publication of the European patent application.
[2014/33]
Type: B1 Patent specification 
No.:EP2763677
Date:26.02.2020
Language:EN
[2020/09]
Search report(s)International search report - published on:US15.05.2014
(Supplementary) European search report - dispatched on:EP17.04.2015
ClassificationIPC:A61K31/535, C07D471/00, A01N43/42, A61K31/44
[2014/33]
CPC:
C07D471/04 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P17/00 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P21/00 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P37/06 (EP);
A61P5/00 (EP); A61P7/04 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/10 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/33]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUE IMMUNSYSTEMMODULATOREN AUF IMIDAZOLCHINOLIN-BASIS[2014/33]
English:NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS[2014/33]
French:NOUVEAUX MODULATEURS DU SYSTÈME IMMUNITAIRE À BASE D'IMIDAZOLE QUINOLINE[2014/33]
Entry into regional phase30.04.2014National basic fee paid 
30.04.2014Search fee paid 
30.04.2014Designation fee(s) paid 
30.04.2014Examination fee paid 
Examination procedure30.04.2014Examination requested  [2014/33]
10.11.2015Amendment by applicant (claims and/or description)
10.04.2017Despatch of a communication from the examining division (Time limit: M04)
25.07.2017Reply to a communication from the examining division
24.08.2017Despatch of a communication from the examining division (Time limit: M04)
21.12.2017Reply to a communication from the examining division
26.04.2018Despatch of a communication from the examining division (Time limit: M02)
28.06.2018Reply to a communication from the examining division
23.01.2019Communication of intention to grant the patent
23.05.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
23.07.2019Communication of intention to grant the patent
29.11.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.11.2019Fee for grant paid
29.11.2019Fee for publishing/printing paid
16.01.2020Information about intention to grant a patent
16.01.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.04.2017
Opposition(s)27.11.2020No opposition filed within time limit [2021/05]
Fees paidRenewal fee
27.10.2014Renewal fee patent year 03
27.10.2015Renewal fee patent year 04
27.10.2016Renewal fee patent year 05
27.10.2017Renewal fee patent year 06
29.10.2018Renewal fee patent year 07
28.10.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.10.2012
AL26.02.2020
AT26.02.2020
CY26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
MK26.02.2020
MT26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
TR26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
BE31.10.2020
[2022/31]
Former [2022/30]HU03.10.2012
AL26.02.2020
AT26.02.2020
CY26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
MT26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
TR26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
BE31.10.2020
Former [2022/27]HU03.10.2012
AT26.02.2020
CY26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
MT26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
TR26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
BE31.10.2020
Former [2022/26]AT26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
TR26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
BE31.10.2020
Former [2021/36]AT26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
BE31.10.2020
Former [2021/31]AT26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
MC26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
LU03.10.2020
Former [2021/10]AT26.02.2020
CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
IT26.02.2020
LT26.02.2020
LV26.02.2020
NL26.02.2020
PL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SI26.02.2020
SK26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
Former [2020/50]CZ26.02.2020
DK26.02.2020
EE26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
LT26.02.2020
LV26.02.2020
NL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SK26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
Former [2020/49]CZ26.02.2020
DK26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
LT26.02.2020
LV26.02.2020
NL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SK26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
Former [2020/48]DK26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
LT26.02.2020
LV26.02.2020
NL26.02.2020
RO26.02.2020
RS26.02.2020
SE26.02.2020
SM26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
PT19.07.2020
Former [2020/47]DK26.02.2020
ES26.02.2020
FI26.02.2020
HR26.02.2020
LT26.02.2020
LV26.02.2020
NL26.02.2020
RS26.02.2020
SE26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
Former [2020/45]FI26.02.2020
HR26.02.2020
LV26.02.2020
NL26.02.2020
RS26.02.2020
SE26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
Former [2020/40]FI26.02.2020
HR26.02.2020
LV26.02.2020
RS26.02.2020
SE26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
IS26.06.2020
Former [2020/39]FI26.02.2020
HR26.02.2020
LV26.02.2020
RS26.02.2020
SE26.02.2020
BG26.05.2020
NO26.05.2020
GR27.05.2020
Former [2020/38]FI26.02.2020
HR26.02.2020
LV26.02.2020
RS26.02.2020
SE26.02.2020
NO26.05.2020
GR27.05.2020
Former [2020/37]FI26.02.2020
HR26.02.2020
LV26.02.2020
RS26.02.2020
SE26.02.2020
NO26.05.2020
Former [2020/35]FI26.02.2020
NO26.05.2020
Documents cited:Search[X]EP0145340  (RIKER LABORATORIES INC [US]) [X] 1,2,12 * page 47; compounds 153,154 *;
 [XI]EP1104764  (HOKURIKU PHARMACEUTICAL [JP]) [X] 1,2,4,6-9,12-14 * paragraphs [0001] , [0009] * * examples 184-186 * * claim 1 * [I] 11,15;
 [A]US2005004144  (CARSON DENNIS A [US], et al) [A] 1-15* claims 1,83 *;
 [X]EP1972629  (MUTABILIS SA [FR]) [X] 1,2,10,12 * page 36, paragraph 216 * * end compound on the right side *;
 [XI]US2010120741  (BORCHARDT ALLEN J [US], et al) [X] 1,2,12-14 * paragraph [0306] * * examples 158-163 * [I] 11,15;
 [A]US2010158928  (STOERMER DORIS [US], et al) [A] 1-15 * paragraph [0233] * * claim 1 *;
 [X]  - CHEN, HAIQUAN ET AL, "Synthesis of derivatives of 1H-imidazo[4,5-c]quinoline", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20070101), Database accession no. 2008:1103424, URL: STN, XP002737903 [X] 1,2,4,12 * abstract * * RN= 1160307-80-1; RN= 1160307-81-2; RN= 1160307-82-3 *
International search[Y]US2007232622  (LIPFORD GRAYSON B [US], et al);
 [Y]US2009069314  (KSHIRSAGAR TUSHAR A [US], et al);
 [Y]US2010160314  (LIPFORD GRAYSON B [US], et al);
 [Y]US2011136801  (ISOBE YOSHIAKI [JP], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.